RU2221794C2 - Arylpiperazine derivatives, methods for their preparing, pharmaceutical composition based on thereof and method for treatment - Google Patents
Arylpiperazine derivatives, methods for their preparing, pharmaceutical composition based on thereof and method for treatment Download PDFInfo
- Publication number
- RU2221794C2 RU2221794C2 RU2001104892/04A RU2001104892A RU2221794C2 RU 2221794 C2 RU2221794 C2 RU 2221794C2 RU 2001104892/04 A RU2001104892/04 A RU 2001104892/04A RU 2001104892 A RU2001104892 A RU 2001104892A RU 2221794 C2 RU2221794 C2 RU 2221794C2
- Authority
- RU
- Russia
- Prior art keywords
- formula
- och
- compound
- propane
- hydrochloride salt
- Prior art date
Links
- 0 CN(C(CCC1*)=O)C1=O Chemical compound CN(C(CCC1*)=O)C1=O 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
- C07D207/408—Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to new arylpiperazine derivatives of the general formula (I): and their pharmaceutically acceptable salts and esters wherein Y represents oxygen atom; Q represents CH; X, Z and Z' each represents independently CH or nitrogen atom; m = 0-1; n = 0-4; R1 and R2 are taken independently among of: hydrogen, fluorine, chlorine, bromine atom, OCH3, OCH2H5, OCH2CF3, CH3, C2H5, CF3, isopropyloxy-group; R3 represents hydrogen atom; R4 and R5 represent hydrogen atom or phenyl with exception that R1 represents Hydrogen atom; R2 represents hydrogen, chlorine atom or CF3; R3,R4,R5 mean hydrogen atom; Y means oxygen atom; Q means CH if m = 0 and n = 1; and with exception that R1 represents hydrogen atom; R2 represents OCH3; R3,R4,R5 mean hydrogen atom; Y means oxygen atom; Q means CH if m = 0 and n = 2. Invention relates also to methods for preparing these compounds, pharmaceutical composition based on thereof eliciting uroselective antagonistic activity with respect to α1- -adrenoceptors and to methods for treatment of beneath prostate hypertrophy, vascular diseases, congested cardiac insufficiency and hypertension. Invention provides preparing new compounds eliciting valuable pharmaceutical properties. EFFECT: improved preparing methods, enhanced treatment methods, valuable medicinal properties of compounds. 27 cl, 6 tbl
Description
Текст описания в факсимильном виде (см. графический материал) Description text in facsimile form (see graphic material)
Claims (21)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/120,265 US6083950A (en) | 1997-11-13 | 1998-07-21 | 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers |
US09/120,265 | 1998-07-21 | ||
IBPCT/IB99/00140 | 1999-01-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001104892A RU2001104892A (en) | 2003-08-27 |
RU2221794C2 true RU2221794C2 (en) | 2004-01-20 |
Family
ID=22389214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001104892/04A RU2221794C2 (en) | 1998-07-21 | 1999-07-16 | Arylpiperazine derivatives, methods for their preparing, pharmaceutical composition based on thereof and method for treatment |
Country Status (10)
Country | Link |
---|---|
CN (1) | CN1168714C (en) |
AR (1) | AR019438A1 (en) |
AU (1) | AU1979799A (en) |
CO (1) | CO5241280A1 (en) |
CZ (1) | CZ2001235A3 (en) |
ID (1) | ID28198A (en) |
MY (1) | MY120255A (en) |
RU (1) | RU2221794C2 (en) |
WO (1) | WO2000005206A1 (en) |
ZA (1) | ZA200100440B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005527578A (en) * | 2002-04-08 | 2005-09-15 | ランバクシー ラボラトリーズ リミテッド | Α, ω-Dicarboximide derivatives as useful urinary selective α1A adrenergic receptor blockers |
US7053355B2 (en) | 2003-03-18 | 2006-05-30 | Brion Technologies, Inc. | System and method for lithography process monitoring and control |
WO2005037281A1 (en) * | 2003-10-15 | 2005-04-28 | Ranbaxy Laboratories Limited | 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist |
WO2005113498A1 (en) * | 2004-05-19 | 2005-12-01 | Ranbaxy Laboratories Limited | Adrenergic receptor antagonists |
WO2005118591A1 (en) * | 2004-05-31 | 2005-12-15 | Ranbaxy Laboratories Limited | Condensed piperidine compounds acting as adrenergic receptor antagonists useful in the treatment of prostatic hyperplasia and lower urinary symptoms |
WO2006018815A1 (en) * | 2004-08-16 | 2006-02-23 | Ranbaxy Laboratories Limited | Piperazine derivatives as adrenergic receptor antagonists |
WO2006051374A2 (en) * | 2004-11-11 | 2006-05-18 | Ranbaxy Laboratories Limited | Arylpiperazines useful as adrenergic receptor antagonists |
CN103864761B (en) * | 2014-03-12 | 2016-01-20 | 天津药物研究院有限公司 | A kind of piperazine derivative containing pyridine and its production and use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE788280A (en) * | 1971-09-04 | 1973-02-28 | Pfizer | NEWS 1- (3-TRIFLUORO-METHYL-PHENYL) -4 - ((CYCLIC AMIDO) - ALKYL) PIPERAZINES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM |
DE2727469A1 (en) * | 1977-06-18 | 1978-12-21 | Hoechst Ag | NEW HEXAHYDROPYRIMIDINE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
JPS57197265A (en) * | 1981-05-29 | 1982-12-03 | Eisai Co Ltd | Carboxylic acid imide derivative, its preparation and medicament containing the same |
US4452798A (en) * | 1982-06-22 | 1984-06-05 | Warner-Lambert Company | 1-Substituted phenyl-4-alkyl hydantoin piperazine compounds as antihypertensive agents |
US4675403A (en) * | 1985-10-16 | 1987-06-23 | American Home Products Corporation | 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity |
ES2094690B1 (en) * | 1994-11-22 | 1997-08-01 | Univ Madrid Complutense | NEW DERIVATIVES OF IMIDA-PIPERAZINES. |
PT748800E (en) * | 1995-06-09 | 2001-10-30 | Hoffmann La Roche | DERIVATIVES OF PYRIMIDINADIONA PYRIMIDINATRIONA TRIAZINADIONA AS ANTAGONISTS OF THE ALPHA-1-ADRENERGIC RECEPTOR |
-
1999
- 1999-01-26 AU AU19797/99A patent/AU1979799A/en not_active Abandoned
- 1999-01-26 WO PCT/IB1999/000140 patent/WO2000005206A1/en active Application Filing
- 1999-07-16 CN CNB998108421A patent/CN1168714C/en not_active Expired - Fee Related
- 1999-07-16 CZ CZ2001235A patent/CZ2001235A3/en unknown
- 1999-07-16 ID IDW20010184A patent/ID28198A/en unknown
- 1999-07-16 RU RU2001104892/04A patent/RU2221794C2/en not_active IP Right Cessation
- 1999-07-20 MY MYPI99003045A patent/MY120255A/en unknown
- 1999-07-21 CO CO99045842A patent/CO5241280A1/en not_active Application Discontinuation
- 1999-07-21 AR ARP990103573A patent/AR019438A1/en not_active Application Discontinuation
-
2001
- 2001-01-16 ZA ZA200100440A patent/ZA200100440B/en unknown
Non-Patent Citations (2)
Title |
---|
C.A. vol.119, no.3, 19.03.1993, no.119:27951y. C.A. vol.105, no.l9, 10.11.1986, no.105:164679. * |
С.А. vol.l28, no.1, 05.01.1998, no.128:128. * |
Also Published As
Publication number | Publication date |
---|---|
WO2000005206A8 (en) | 2000-03-16 |
CN1168714C (en) | 2004-09-29 |
AR019438A1 (en) | 2002-02-20 |
ZA200100440B (en) | 2002-10-04 |
CZ2001235A3 (en) | 2001-08-15 |
MY120255A (en) | 2005-09-30 |
CO5241280A1 (en) | 2003-01-31 |
CN1318052A (en) | 2001-10-17 |
AU1979799A (en) | 2000-02-14 |
ID28198A (en) | 2001-05-10 |
WO2000005206A1 (en) | 2000-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2326869C2 (en) | Pyridazine 3(2h) derivatives as inhibitor of phosphodiesterase 4 (pde4), method of their preparation, pharmaceutical composition and method of treatment | |
RU2324684C2 (en) | Pyrimidine derivatives | |
RU2002122095A (en) | NEW PIPYRIDINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION | |
CN100383124C (en) | Quinoline derivatives as NPY antagonists | |
RU2005102592A (en) | INDOLINPHENYL SULFAMIDE DERIVATIVES | |
JP2001526223A5 (en) | ||
RU2221794C2 (en) | Arylpiperazine derivatives, methods for their preparing, pharmaceutical composition based on thereof and method for treatment | |
RU2002123350A (en) | Dipeptidnitrile Cathepsin K Inhibitors | |
JP2003507328A5 (en) | ||
RU2000117278A (en) | DERIVATIVE 2-ARYL-8-OXODYHYDROPURIN, METHOD FOR ITS PREPARATION, CONTAINING ITS PHARMACEUTICAL COMPOSITION, AND INTERMEDIATE CONNECTION | |
JP2002534519A5 (en) | ||
RU2004135064A (en) | NEW SUBSTITUTED INDOS | |
RU2003129502A (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, APPLICATION, METHOD FOR PREVENTING OR TREATING DISEASES | |
JP2007519754A5 (en) | ||
RU2000129161A (en) | DERIVATIVE 1 - [(1-SUBSTITUTED-4-PIPERIDINYL) METHYL] -4-PIPERIDINE, METHOD FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION CONTAINING THE INDICATED COMPOUND, AND THE INTERMEDIATE PRODUCT | |
ATE464292T1 (en) | PHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES | |
KR880000180B1 (en) | Process for preparing dihydropyridimes | |
RU97114306A (en) | Phenyl-substituted guanidines of alkenylcarboxylic acid, a method for their preparation, their use as a medicine or diagnostic tool, and also containing their medicine | |
MXPA05010816A (en) | 4- (4-(heterocyclylalkoxy} phenyl)-1 -(heterocyclyl- carbonyl) piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer. | |
CA2321198A1 (en) | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists | |
RU2002133458A (en) | Compounds of piperazine and piperidine | |
RU2221788C2 (en) | Urea oxocyclic compounds, pharmaceutical composition, treatment method | |
JP2010504321A5 (en) | ||
RU2010126842A (en) | PIPERASIN DERIVATIVES AND THEIR APPLICATION AS LEPTIN RECEPTOR MODULATORS | |
RU2001104892A (en) | ARILPIPERAZINE DERIVATIVES, METHODS FOR PRODUCING THEM, PHARMACEUTICAL COMPOSITION ON THE BASIS AND METHODS OF TREATMENT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20060717 |